Study on the predictive efficacy of Ki-67, ER, and PR levels on the effectiveness of neoadjuvant chemotherapy in breast cancer
AimTo investigate the predictive efficacy of Ki-67 antigen (Ki-67), estrogen receptor (ER), and progesterone receptor (PR) levels on the effectiveness of neoadjuvant chemotherapy (NAC) in breast cancer.MethodsA total of 720 breast cancer patients receiving NAC at our hospital from September 2022 to...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Frontiers Media S.A.
2026-07-01
|
| Серія: | Frontiers in Medicine |
| Предмети: | |
| Онлайн доступ: | https://www.frontiersin.org/articles/10.3389/fmed.2026.1780629/full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|